ARCHIVES

RFA/PA/Drug Group Announcement Limited

This article is from The Cancer Letter archive.

Vol. 14 No. 19 | May 6, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998